OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
17 hedge funds and large institutions have $265K invested in OncoSec Medical Incorporated in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 1 reducing their positions, and 10 closing their positions.
800% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 1
26% less funds holding
Funds holding: 23 → 17 (-6)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
89% less capital invested
Capital invested by funds: $2.51M → $265K (-$2.25M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$130K |
| 2 |
Renaissance Technologies
New York
|
+$118K |
| 3 |
Two Sigma Investments
New York
|
+$118K |
| 4 |
VF
Virtu Financial
New York
|
+$69.7K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$69.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$1.44M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$350K |
| 3 |
TAM
Tocqueville Asset Management
New York
|
-$37K |
| 4 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
-$34K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$30K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citadel Advisors
Miami,
Florida
| – | -$8K | -711 | Closed |
|
|
MSAM
27
Moloney Securities Asset Management
Manchester,
Missouri
| – | -$6K | -539 | Closed |
|
ONCS Hedge Fund Activity: Q4 2022 in Review
17 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q4 2022, worth a combined $265K — down 89% from $2.51M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ONCS and 5 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 9 added.
The largest buyer was State Street, adding an estimated $130K. The largest seller was Avidity Partners Management, exiting entirely with an estimated $1.44M sold.
- 17 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q4 2022, down from 23 in Q3 2022.
- Funds reported $265K of OncoSec Medical Incorporated stock for Q4 2022, down 89% quarter-over-quarter.
- 5 funds opened new OncoSec Medical Incorporated positions in Q4 2022 and 10 closed out, a net change of -5 holders.
- The largest OncoSec Medical Incorporated buyer in Q4 2022 was State Street, an estimated $130K added.
- The largest OncoSec Medical Incorporated seller in Q4 2022 was Avidity Partners Management, an estimated $1.44M sold.
Based on aggregated 13F filings for Q4 2022.